CoreCap Advisors’s Boston Scientific BSX Stock Holding History

CoreCap Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.7K	Buy	2,312 +157	+7%	+$8.53K	﹤0.01%	1106
2026 Q1	$135K	Sell	2,155 -491	-19%	-$39.3K	﹤0.01%	928
2025 Q4	$252K	Buy	2,646 +748	+39%	+$73.3K	0.01%	713
2025 Q3	$185K	Sell	1,898 -71	-4%	-$7.35K	0.01%	822
2025 Q2	$211K	Sell	1,969 -21,322	-92%	-$2.16M	0.01%	726
2025 Q1	$2.35M	Sell	23,291 -5,991	-20%	-$603K	0.1%	188
2024 Q4	$2.62M	Buy	29,282 +24,717	+541%	+$2.18M	0.12%	170
2024 Q3	$383K	Buy	+4,565	New	+$360K	0.02%	521
2024 Q2	–	Sell	-3,508	Closed	-$240K	–	1735
2024 Q1	$240K	Buy	+3,508	New	+$226K	0.01%	578
2022 Q4	$81.5K	Buy	+1,762	New	+$76.3K	0.01%	805
2022 Q3	–	Sell	-712	Closed	-$27K	–	734
2022 Q2	$27K	Buy	+712	New	+$29K	﹤0.01%	1134
2022 Q1	–	Sell	-2,362	Closed	-$100K	–	746
2021 Q4	$100K	Buy	+2,362	New	+$99.3K	0.01%	744

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

CoreCap Advisors's BSX Position: Q2 2026 in Review

CoreCap Advisors increased its Boston Scientific (BSX) stake by 7.3% in Q2 2026, buying an estimated $8.53K and bringing the position to 2,312 shares worth $98.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

CoreCap Advisors first reported a position in BSX in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.62M in Q4 2024. 267 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

CoreCap Advisors held 2,312 shares of Boston Scientific worth $98.7K as of Q2 2026.
CoreCap Advisors bought 157 Boston Scientific shares in Q2 2026, an estimated $8.53K.
Boston Scientific made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1106 holding.
CoreCap Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 12 quarters since.
CoreCap Advisors's Boston Scientific position peaked at $2.62M in Q4 2024.
267 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.